SENSEX NIFTY
Expert & Brokerage views on Dr Reddys Labs

See Nuvaring opportunity for Dr Reddy's in Q4FY18: Credit Suisse

01:39 PM | Aug 29, 2016 | Source: Moneycontrol.com

Nuvaring is the largest of the eight products that Dr Reddy's has bought from Teva in June 2016. DRL...

Accumulate Dr. Reddy’s Lab; target of Rs 3,366: KRChoksey

04:22 PM | Jul 29, 2016 | Source: Moneycontrol.com

KRChoksey is bullish on Dr. Reddy’s Laboratories has recommended accumulate rating on the stock wi...

Sell Dr Reddy's; target of Rs 2650: Axis Direct

01:35 PM | Jul 29, 2016 | Source: Moneycontrol.com

Axis Direct is bearish on Dr Reddy's has recommended sell rating on the stock with a target price of...

Sell Dr Reddys; target of Rs 2800: Religare

12:49 PM | Jul 29, 2016 | Source: Moneycontrol.com

Religare is bearish on Dr Reddys has recommended sell rating on the stock with a target price of Rs ...

Dr Reddy's Labs will head to Rs 4500, says Sudarshan Sukhani

09:08 AM | Jul 27, 2016 | Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that Dr Reddy's Labs will eventually go to Rs 4,...

Hold Dr. Reddys; target of Rs 3280: Religare

04:16 PM | Jun 29, 2016 | Source: Moneycontrol.com

Religare recommended hold rating on Dr. Reddys with a target price of Rs 3280 in its research report...

Hold Dr Reddys Labs; target of Rs 3280 : Religare

05:53 PM | Jun 13, 2016 | Source: Moneycontrol.com

Religare has recommended hold rating on Dr Reddys Labs with a target of Rs 3280 in its research rep...

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 29, 2016)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
2400

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1429

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1429

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.